GADGVGKSAL
GADGVGKSAL is a mutant KRAS G12D 10mer peptide. GADGVGKSAL can be used as an immunogenic neoantigen for cancer immunotherapy research[1].
Product Specifications
CAS Number
[199477-24-2]
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gadgvgksal.html
Purity
98.62
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)C[C@@H](C(O)=O)NC([C@H](C)NC([C@H](CO)NC([C@H](CCCCN)NC(CNC([C@H](C(C)C)NC(CNC([C@H](CC(O)=O)NC([C@H](C)NC(CN)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C36H63N11O14
Molecular Weight
873.95
References & Citations
[1]Bai P, et al. Characters of neoantigens in cancer immunotherapy. bioRxiv, 2019: 700732.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NAK (S172) (TBK, Serine/Threonine-protein Kinase TBK1, TANK-binding Kinase 1, T2K, NF-kappa-B-activating Kinase, TBK1) (MaxLight 405)
NAK (S172) (TBK, Serine/Threonine-protein Kinase TBK1, TANK-binding Kinase 1, T2K, NF-kappa-B-activating Kinase, TBK1) (MaxLight 405)
